{
  "actions": [
    {
      "acted_at": "2016-09-28", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2016-09-28", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr6284-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "114", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2016-09-28", 
  "number": "6284", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Eliminate Price Increases Act of 2016", 
  "sponsor": {
    "bioguide_id": "S000510", 
    "district": "9", 
    "name": "Smith, Adam", 
    "state": "WA", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2016-09-28", 
  "subjects": [
    "Health"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2016-09-28T04:00:00Z", 
    "text": "Eliminate Price Increases Act of 2016 or the EPI Act\n\nThis bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the manufacturer of a brand name drug from authorizing or commencing the manufacturing, marketing, selling, or distributing of a generic version of the drug from the time the manufacturer is notified by a generic manufacturer that a generic drug application has been submitted until the expiration or forfeiture of the 180-day exclusivity period granted to the generic manufacturer."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Eliminate Price Increases Act of 2016", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "EPI Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "EPI Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2018-11-21T21:23:53Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/114/hr/BILLSTATUS-114hr6284.xml"
}